Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Bibliografiska uppgifter
I publikationen:Philippine Star Vol. 34, no. 183 (26 Jan. 2020), 9
Huvudupphovsman: Chante, Charles C.
Materialtyp: Artikel
Publicerad: 2020
Ämnen:
Heart diseases
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Heart failure